{"id": "IEPA.d1.s1_IEPA.d1.s1.p0", "text": "Phosphoinositide hydrolysis, resulting in inositol trisphosphate (IP3) and diacylglycerol (DG) formation, has been implicated in oxytocin-stimulated pulsatile secretion of prostaglandin F2 alpha (PGF2 alpha) from uterine endometrium of sheep and other mammals", "text_with_entity_marker": "Phosphoinositide hydrolysis, resulting in [E1]inositol trisphosphate[/E1] (IP3) and diacylglycerol (DG) formation, has been implicated in [E2]oxytocin[/E2]-stimulated pulsatile secretion of prostaglandin F2 alpha (PGF2 alpha) from uterine endometrium of sheep and other mammals", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "inositol trisphosphate", "entity_1_idx": [[42, 64]], "entity_1_idx_in_text_with_entity_marker": [46, 68], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[129, 137]], "entity_2_idx_in_text_with_entity_marker": [142, 150], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d5.s10_IEPA.d5.s10.p0", "text": "For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM oxytocin (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and IP3, respectively) were quantified", "text_with_entity_marker": "For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM [E1]oxytocin[/E1] (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and [E2]IP3[/E2], respectively) were quantified", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[129, 137]], "entity_1_idx_in_text_with_entity_marker": [133, 141], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d7.s13_IEPA.d7.s13.p0", "text": "Hesperidin, the most important flavanone of Citrus sp., significantly increases HDL and lowers cholesterol, LDL, total lipid and triglyceride plasma levels in normolipidemic rats and in rats with diet- and triton-induced hyperlipidemia", "text_with_entity_marker": "Hesperidin, the most important [E1]flavanone[/E1] of Citrus sp., significantly increases HDL and lowers [E2]cholesterol[/E2], LDL, total lipid and triglyceride plasma levels in normolipidemic rats and in rats with diet- and triton-induced hyperlipidemia", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flavanone", "entity_1_idx": [[31, 40]], "entity_1_idx_in_text_with_entity_marker": [35, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[95, 106]], "entity_2_idx_in_text_with_entity_marker": [108, 119], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d9.s18_IEPA.d9.s18.p0", "text": "Oxytocin induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, inositol 1,4,5-trisphosphate-sensitive Ca2+ pool, and Ca2+ channels", "text_with_entity_marker": "[E1]Oxytocin[/E1] induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, [E2]inositol 1,4,5-trisphosphate[/E2]-sensitive Ca2+ pool, and Ca2+ channels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[164, 192]], "entity_2_idx_in_text_with_entity_marker": [177, 205], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d12.s29_IEPA.d12.s29.p2", "text": "These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway", "text_with_entity_marker": "These results suggest that APP-S secretion and [E1]A beta[/E1] production in NT2N neurons are regulated by the muscarinic/[E2]phospholipase C[/E2] signal transduction pathway", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A beta", "entity_1_idx": [[47, 53]], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[113, 128]], "entity_2_idx_in_text_with_entity_marker": [126, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d13.s30_IEPA.d13.s30.p0", "text": "Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary cholesterol, soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as flavonoid compounds in some soy products", "text_with_entity_marker": "Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary [E1]cholesterol[/E1], soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as [E2]flavonoid[/E2] compounds in some soy products", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cholesterol", "entity_1_idx": [[176, 187]], "entity_1_idx_in_text_with_entity_marker": [180, 191], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavonoid", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d15.s32_IEPA.d15.s32.p0", "text": "The beta amyloid protein fragments had diverse effects on phosphoinositide-specific phospholipase C (PI-PLC) as assayed in rat cortical membranes", "text_with_entity_marker": "The beta [E1]amyloid[/E1] protein fragments had diverse effects on phosphoinositide-specific [E2]phospholipase C[/E2] (PI-PLC) as assayed in rat cortical membranes", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[9, 16]], "entity_1_idx_in_text_with_entity_marker": [13, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[84, 99]], "entity_2_idx_in_text_with_entity_marker": [97, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s39_IEPA.d17.s39.p0", "text": "The present study demonstrates that hCG and oxytocin can increase the accumulation of inositol phosphates in porcine myometrial cells", "text_with_entity_marker": "The present study demonstrates that hCG and [E1]oxytocin[/E1] can increase the accumulation of [E2]inositol phosphates[/E2] in porcine myometrial cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphates", "entity_2_idx": [[86, 105]], "entity_2_idx_in_text_with_entity_marker": [99, 118], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p3", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal [E1]prion protein[/E1] isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific [E2]kinase[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[446, 452]], "entity_2_idx_in_text_with_entity_marker": [459, 465], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p6", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular [E1]prion protein[/E1] isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific [E2]kinase[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[193, 206]], "entity_1_idx_in_text_with_entity_marker": [197, 210], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[446, 452]], "entity_2_idx_in_text_with_entity_marker": [459, 465], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p7", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal [E1]prion protein[/E1] isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a [E2]prion protein[/E2]-specific kinase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[269, 282]], "entity_1_idx_in_text_with_entity_marker": [273, 286], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[423, 436]], "entity_2_idx_in_text_with_entity_marker": [436, 449], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d25.s54_IEPA.d25.s54.p0", "text": "The responses of serum oxytocin (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an insulin (0.15 iu/kg as an i.v. bolus) tolerance test (ITT)", "text_with_entity_marker": "The responses of serum [E1]oxytocin[/E1] (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an [E2]insulin[/E2] (0.15 iu/kg as an i.v. bolus) tolerance test (ITT)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[23, 31]], "entity_1_idx_in_text_with_entity_marker": [27, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[249, 256]], "entity_2_idx_in_text_with_entity_marker": [262, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d25.s55_IEPA.d25.s55.p0", "text": "Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor OT response to insulin-induced hypoglycemia", "text_with_entity_marker": "Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor [E1]OT[/E1] response to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[86, 88]], "entity_1_idx_in_text_with_entity_marker": [90, 92], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[101, 108]], "entity_2_idx_in_text_with_entity_marker": [114, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d27.s59_IEPA.d27.s59.p0", "text": "In previous experiments, we have shown that following i.c.v. application of oxytocin, plasma levels of insulin are increased through a cholinergic mechanism", "text_with_entity_marker": "In previous experiments, we have shown that following i.c.v. application of [E1]oxytocin[/E1], plasma levels of [E2]insulin[/E2] are increased through a cholinergic mechanism", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[103, 110]], "entity_2_idx_in_text_with_entity_marker": [116, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d35.s86_IEPA.d35.s86.p1", "text": "Oxytocin (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F", "text_with_entity_marker": "[E1]Oxytocin[/E1] (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke [E2]insulin[/E2] secretion from the rat insulinoma cell line, RINm5F", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d38.s92_IEPA.d38.s92.p1", "text": "2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and insulin and totally inhibited the effect of IGF-2", "text_with_entity_marker": "2) IGF-1, IGF-2, and [E1]insulin[/E1] also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and [E2]insulin[/E2] and totally inhibited the effect of IGF-2", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[21, 28]], "entity_1_idx_in_text_with_entity_marker": [25, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d38.s92_IEPA.d38.s92.p2", "text": "2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and insulin and totally inhibited the effect of IGF-2", "text_with_entity_marker": "2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: [E1]phospholipase C[/E1] (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and [E2]insulin[/E2] and totally inhibited the effect of IGF-2", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[94, 109]], "entity_1_idx_in_text_with_entity_marker": [98, 113], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d39.s95_IEPA.d39.s95.p0", "text": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum", "text_with_entity_marker": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of [E1]insulin[/E1]-[E2]phospholipase C[/E2] conjugate were inhibited in the presence of insulin antiserum", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[97, 112]], "entity_2_idx_in_text_with_entity_marker": [110, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s99_IEPA.d40.s99.p0", "text": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "text_with_entity_marker": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced [E1]insulin[/E1] secretion in primed islets but that [E2]PLC[/E2] activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[107, 114]], "entity_1_idx_in_text_with_entity_marker": [111, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[151, 154]], "entity_2_idx_in_text_with_entity_marker": [164, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s118_IEPA.d46.s118.p0", "text": "Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein stimulation of [E2]phospholipase C[/E2] was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[36, 51]], "entity_2_idx_in_text_with_entity_marker": [49, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s118_IEPA.d46.s118.p2", "text": "Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "text_with_entity_marker": "Amyloid beta protein stimulation of [E1]phospholipase C[/E1] was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or [E2]amyloid[/E2] beta peptide", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[36, 51]], "entity_1_idx_in_text_with_entity_marker": [40, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[192, 199]], "entity_2_idx_in_text_with_entity_marker": [205, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p2", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal [E1]insulin[/E1] responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of [E2]OT[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[12, 19]], "entity_1_idx_in_text_with_entity_marker": [16, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[170, 172]], "entity_2_idx_in_text_with_entity_marker": [183, 185], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p3", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal insulin responses induced by [E1]OT[/E1] and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma [E2]insulin[/E2] were higher than those of OT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d49.s126_IEPA.d49.s126.p0", "text": "Leptin upregulates the expression of uncoupling protein-2 (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors", "text_with_entity_marker": "[E1]Leptin[/E1] upregulates the expression of [E2]uncoupling protein-2[/E2] (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[37, 57]], "entity_2_idx_in_text_with_entity_marker": [50, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s129_IEPA.d50.s129.p2", "text": "A specific enhancement in PLC-mediated insulin secretion is the earliest reported developmental alteration in insulin secretion from islets of ob/ob mice, and thus a logical target for leptin action", "text_with_entity_marker": "A specific enhancement in PLC-mediated [E1]insulin[/E1] secretion is the earliest reported developmental alteration in [E2]insulin[/E2] secretion from islets of ob/ob mice, and thus a logical target for leptin action", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[39, 46]], "entity_1_idx_in_text_with_entity_marker": [43, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[110, 117]], "entity_2_idx_in_text_with_entity_marker": [123, 130], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s132_IEPA.d50.s132.p0", "text": "One function of leptin in control of body composition is thus to target a PKC-regulated component of the PLC-PKC signaling system within islets to prevent hypersecretion of insulin", "text_with_entity_marker": "One function of leptin in control of body composition is thus to target a PKC-regulated component of the [E1]PLC[/E1]-PKC signaling system within islets to prevent hypersecretion of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[105, 108]], "entity_1_idx_in_text_with_entity_marker": [109, 112], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[173, 180]], "entity_2_idx_in_text_with_entity_marker": [186, 193], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d54.s138_IEPA.d54.s138.p1", "text": "This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of AVP concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective", "text_with_entity_marker": "This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of [E1]AVP[/E1] concentrations) and involves the V2 receptor pathway, while activation of [E2]protein kinase C[/E2] or changes in intracellular calcium are ineffective", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[104, 107]], "entity_1_idx_in_text_with_entity_marker": [108, 111], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[182, 198]], "entity_2_idx_in_text_with_entity_marker": [195, 211], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s139_IEPA.d55.s139.p0", "text": "After protein kinase C activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, AVP did not augment IL-1beta-induced NO production", "text_with_entity_marker": "After [E1]protein kinase C[/E1] activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, [E2]AVP[/E2] did not augment IL-1beta-induced NO production", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s141_IEPA.d55.s141.p0", "text": "The addition of AVP increased protein kinase C activity in cardiac myocytes, and its effect was significantly inhibited in the presence of calphostin C", "text_with_entity_marker": "The addition of [E1]AVP[/E1] increased [E2]protein kinase C[/E2] activity in cardiac myocytes, and its effect was significantly inhibited in the presence of calphostin C", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[30, 46]], "entity_2_idx_in_text_with_entity_marker": [43, 59], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s142_IEPA.d55.s142.p2", "text": "These results support the hypothesis that the heart may be a target organ for AVP and that AVP modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C", "text_with_entity_marker": "These results support the hypothesis that the heart may be a target organ for AVP and that [E1]AVP[/E1] modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of [E2]protein kinase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[91, 94]], "entity_1_idx_in_text_with_entity_marker": [95, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[231, 247]], "entity_2_idx_in_text_with_entity_marker": [244, 260], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d64.s162_IEPA.d64.s162.p0", "text": "In contrast, AVP had no effect on the distribution of any PKC isoform tested", "text_with_entity_marker": "In contrast, [E1]AVP[/E1] had no effect on the distribution of any [E2]PKC[/E2] isoform tested", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[58, 61]], "entity_2_idx_in_text_with_entity_marker": [71, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d65.s163_IEPA.d65.s163.p0", "text": "Vasopressin-induced activation of protein kinase C in renal epithelial cells", "text_with_entity_marker": "[E1]Vasopressin[/E1]-induced activation of [E2]protein kinase C[/E2] in renal epithelial cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Vasopressin", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[34, 50]], "entity_2_idx_in_text_with_entity_marker": [47, 63], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p5", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E1]PLCgamma[/E1] to block [E2]insulin[/E2]-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLCgamma", "entity_1_idx": [[216, 224]], "entity_1_idx_in_text_with_entity_marker": [220, 228], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[234, 241]], "entity_2_idx_in_text_with_entity_marker": [247, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d70.s171_IEPA.d70.s171.p1", "text": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia", "text_with_entity_marker": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and [E1]OT[/E1] and the OT response to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[118, 120]], "entity_1_idx_in_text_with_entity_marker": [122, 124], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p2", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular [E1]leptin[/E1] administration was accompanied by the maintenance of high UCP1, UCP2, and [E2]UCP3[/E2] expression in all these tissues", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[44, 50]], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p5", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, [E1]UCP2[/E1], and [E2]UCP3[/E2] expression in all these tissues", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p0", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While [E1]leptin[/E1] maintains or favors energy-dissipating mechanisms ([E2]UCP1[/E2], UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[64, 68]], "entity_2_idx_in_text_with_entity_marker": [77, 81], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s187_IEPA.d78.s187.p1", "text": "To assess the possible involvement of PKC in AVP and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested", "text_with_entity_marker": "To assess the possible involvement of [E1]PKC[/E1] in AVP and IL-1 action in Leydig cells, the [E2]PKC[/E2] inhibitor Calphostin C was tested", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d82.s197_IEPA.d82.s197.p0", "text": "Next, we determined that leptin decreases NPY and increases UCP gene expression", "text_with_entity_marker": "Next, we determined that [E1]leptin[/E1] decreases NPY and increases [E2]UCP[/E2] gene expression", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d87.s206_IEPA.d87.s206.p0", "text": "These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of PLC, leading to intracellular translocation of insulin granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains", "text_with_entity_marker": "These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of [E1]PLC[/E1], leading to intracellular translocation of [E2]insulin[/E2] granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[127, 130]], "entity_1_idx_in_text_with_entity_marker": [131, 134], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[174, 181]], "entity_2_idx_in_text_with_entity_marker": [187, 194], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p6", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and [E1]UCP2[/E1] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s209_IEPA.d89.s209.p2", "text": "UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin", "text_with_entity_marker": "[E1]UCP2[/E1], UCP3 and leptin gene expression: modulation by food restriction and [E2]leptin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s210_IEPA.d89.s210.p1", "text": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "text_with_entity_marker": "To determine the effects of food restriction and [E1]leptin[/E1] administration on several transcripts involved in energy homeostasis, we examined leptin, [E2]uncoupling proteins[/E2] (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[146, 165]], "entity_2_idx_in_text_with_entity_marker": [159, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s211_IEPA.d89.s211.p4", "text": "Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "text_with_entity_marker": "Leptin increased LPL mRNA by 80%, [E1]UCP1[/E1] mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased [E2]UCP2[/E2] mRNA levels twofold in EWAT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s218_IEPA.d91.s218.p0", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the [E1]Oxy[/E1]-induced increases in [Ca2+]i and [E2]IP3[/E2]; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s233_IEPA.d96.s233.p2", "text": "Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "text_with_entity_marker": "Denervation suppressed mRNA levels for UCP-2 (49%), [E1]UCP-3[/E1] (36%), and COX-IV (59%) and eliminated the acute response to [E2]leptin[/E2] in SM", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-3", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[119, 125]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d97.s234_IEPA.d97.s234.p0", "text": "The specific protein kinase C (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, AVP-, PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively", "text_with_entity_marker": "The specific [E1]protein kinase C[/E1] (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, [E2]AVP[/E2]-, PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[13, 29]], "entity_1_idx_in_text_with_entity_marker": [17, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s252_IEPA.d108.s252.p1", "text": "The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous oxytocin and glucose", "text_with_entity_marker": "The present study was designed to investigate how repeated injections of [E1]oxytocin[/E1] influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous [E2]oxytocin[/E2] and glucose", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[228, 236]], "entity_2_idx_in_text_with_entity_marker": [241, 249], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p2", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without [E1]leptin[/E1] administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT [E2]UCP-2[/E2] mRNA, to 138% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s265_IEPA.d110.s265.p0", "text": "The Ca2+ ionophore, A23187 or ionomycin, mimicked the effect of AVP, whereas the protein kinase C (PKC) activator, TPA, only induced a slight increase in AA release", "text_with_entity_marker": "The Ca2+ ionophore, A23187 or ionomycin, mimicked the effect of [E1]AVP[/E1], whereas the [E2]protein kinase C[/E2] (PKC) activator, TPA, only induced a slight increase in AA release", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[64, 67]], "entity_1_idx_in_text_with_entity_marker": [68, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[81, 97]], "entity_2_idx_in_text_with_entity_marker": [94, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d111.s269_IEPA.d111.s269.p0", "text": "Plasma oxytocin, and some functionally related peptides (CCK, gastrin, somatostatin and insulin), were measured by standard radioimmunoassay techniques", "text_with_entity_marker": "Plasma [E1]oxytocin[/E1], and some functionally related peptides (CCK, gastrin, somatostatin and [E2]insulin[/E2]), were measured by standard radioimmunoassay techniques", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[7, 15]], "entity_1_idx_in_text_with_entity_marker": [11, 19], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s274_IEPA.d114.s274.p2", "text": "In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats", "text_with_entity_marker": "In normal pancreatic islets, UCP-2 is upregulated by [E1]leptin[/E1] and is low in [E2]leptin[/E2]-resistant islets of ZDF rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[53, 59]], "entity_1_idx_in_text_with_entity_marker": [57, 63], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p5", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive [E1]UCP-2[/E1]-underexpressing islets of diabetic ZDF rats, we transferred the [E2]UCP-2[/E2] gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[168, 173]], "entity_1_idx_in_text_with_entity_marker": [172, 177], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s281_IEPA.d115.s281.p0", "text": "Overexpression of PLC-beta1 or -beta3 in normal rat islets  elicits a larger increase in IP accumulation but, again, has no effect on  insulin secretion.", "text_with_entity_marker": "Overexpression of [E1]PLC[/E1]-beta1 or -beta3 in normal rat islets  elicits a larger increase in IP accumulation but, again, has no effect on  [E2]insulin[/E2] secretion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d117.s285_IEPA.d117.s285.p5", "text": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "text_with_entity_marker": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [[E1]GA3[/E1]] for both leaf elongation and [E2]alpha-amylase[/E2] production by aleurone", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA3", "entity_1_idx": [[131, 134]], "entity_1_idx_in_text_with_entity_marker": [135, 138], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s290_IEPA.d122.s290.p0", "text": "Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue", "text_with_entity_marker": "Effects of intravenously infused [E1]leptin[/E1] on insulin sensitivity and on the expression of [E2]uncoupling proteins[/E2] in brown adipose tissue", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[88, 107]], "entity_2_idx_in_text_with_entity_marker": [101, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d125.s298_IEPA.d125.s298.p1", "text": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote APP secretion, whereas inhibition of MAP kinase will reduce APP secretion only when phospholipase Cgamma or phosphatidylinositol 3-kinase are additionally inhibited", "text_with_entity_marker": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote [E1]APP[/E1] secretion, whereas inhibition of MAP kinase will reduce APP secretion only when [E2]phospholipase Cgamma[/E2] or phosphatidylinositol 3-kinase are additionally inhibited", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APP", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma", "entity_2_idx": [[195, 215]], "entity_2_idx_in_text_with_entity_marker": [208, 228], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p11", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT [E1]leptin[/E1] mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and [E2]UCP3[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[153, 159]], "entity_1_idx_in_text_with_entity_marker": [157, 163], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s302_IEPA.d127.s302.p0", "text": "When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "text_with_entity_marker": "When this parental line was treated with [E1]PI-PLC[/E1], [E2]Abeta40[/E2], Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PI-PLC", "entity_1_idx": [[41, 47]], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Abeta40", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s302_IEPA.d127.s302.p3", "text": "When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "text_with_entity_marker": "When this parental line was treated with PI-PLC, [E1]Abeta40[/E1], [E2]Abeta42[/E2], and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abeta40", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Abeta42", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s310_IEPA.d129.s310.p0", "text": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control", "text_with_entity_marker": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma [E1]leptin[/E1] approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) [E2]leptin[/E2] mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[76, 82]], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[160, 166]], "entity_2_idx_in_text_with_entity_marker": [173, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p3", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal [E1]PIP2-PLC[/E1] activity and cytosolic [E2]PI-PLC[/E2] and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIP2-PLC", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[78, 84]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s320_IEPA.d132.s320.p0", "text": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "text_with_entity_marker": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited [E1]gibberellin[/E1]-inducible [E2]alpha-amylase[/E2] induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[226, 237]], "entity_1_idx_in_text_with_entity_marker": [230, 241], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[248, 261]], "entity_2_idx_in_text_with_entity_marker": [261, 274], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s320_IEPA.d132.s320.p1", "text": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "text_with_entity_marker": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited [E1]gibberellin[/E1]-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of [E2]alpha-amylase[/E2] production", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gibberellin", "entity_1_idx": [[226, 237]], "entity_1_idx_in_text_with_entity_marker": [230, 241], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[359, 372]], "entity_2_idx_in_text_with_entity_marker": [372, 385], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s332_IEPA.d138.s332.p0", "text": "The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase", "text_with_entity_marker": "The data suggest that mammalian [E1]insulin[/E1]-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and [E2]GPI-PLC[/E2]) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s370_IEPA.d154.s370.p0", "text": "The glycosyl-phosphatidylinositol anchored protein, membrane dipeptidase (EC 3.4.13.19) is released from the surface of 3T3-L1 adipocytes in response to insulin treatment through the action of a phospholipase C", "text_with_entity_marker": "The glycosyl-phosphatidylinositol anchored protein, membrane dipeptidase (EC 3.4.13.19) is released from the surface of 3T3-L1 adipocytes in response to [E1]insulin[/E1] treatment through the action of a [E2]phospholipase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[195, 210]], "entity_2_idx_in_text_with_entity_marker": [208, 223], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s371_IEPA.d154.s371.p0", "text": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "text_with_entity_marker": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific [E1]phospholipase C[/E1], it was not released upon [E2]insulin[/E2] treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[148, 163]], "entity_1_idx_in_text_with_entity_marker": [152, 167], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[190, 197]], "entity_2_idx_in_text_with_entity_marker": [203, 210], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s371_IEPA.d154.s371.p1", "text": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "text_with_entity_marker": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific [E1]phospholipase C[/E1], it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to [E2]insulin[/E2]-stimulated release", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[148, 163]], "entity_1_idx_in_text_with_entity_marker": [152, 167], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[300, 307]], "entity_2_idx_in_text_with_entity_marker": [313, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p1", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, [E1]leptin[/E1], UCP-2, [E2]UCP-3[/E2], and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s391_IEPA.d162.s391.p0", "text": "These findings suggest that the regulation of hypothalamic NPY mRNA by leptin may be impaired with age", "text_with_entity_marker": "These findings suggest that the regulation of hypothalamic [E1]NPY[/E1] mRNA by [E2]leptin[/E2] may be impaired with age", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NPY", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[71, 77]], "entity_2_idx_in_text_with_entity_marker": [84, 90], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s393_IEPA.d162.s393.p2", "text": "Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats", "text_with_entity_marker": "Leptin infusion diminished hypothalamic [E1]NPY[/E1] levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic [E2]NPY[/E2] mRNA levels in senescent rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s394_IEPA.d162.s394.p0", "text": "These diminished responses to leptin were associated with and may be the result of an impaired suppression of hypothalamic NPY mRNA levels", "text_with_entity_marker": "These diminished responses to [E1]leptin[/E1] were associated with and may be the result of an impaired suppression of hypothalamic [E2]NPY[/E2] mRNA levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p5", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of [E1]leptin[/E1] prevented such a decrease in [E2]UCP-3[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[223, 229]], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s417_IEPA.d172.s417.p1", "text": "However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "text_with_entity_marker": "However, both EGF and [E1]insulin[/E1] stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of [E2]insulin[/E2]- stimulated cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s418_IEPA.d172.s418.p0", "text": "Therefore, it is suggested that the insulin-induced coclustering of the EGF receptor with phospholipase Cgamma1 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.", "text_with_entity_marker": "Therefore, it is suggested that the [E1]insulin[/E1]-induced coclustering of the EGF receptor with [E2]phospholipase Cgamma1[/E2] at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[36, 43]], "entity_1_idx_in_text_with_entity_marker": [40, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[90, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d176.s425_IEPA.d176.s425.p0", "text": "For example, leptin suppresses neuropeptide Y (NPY) expression in the arcuate nucleus", "text_with_entity_marker": "For example, [E1]leptin[/E1] suppresses [E2]neuropeptide Y[/E2] (NPY) expression in the arcuate nucleus", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[31, 45]], "entity_2_idx_in_text_with_entity_marker": [44, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s427_IEPA.d177.s427.p2", "text": "Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression", "text_with_entity_marker": "Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum [E1]leptin[/E1] concentrations and hypothalamic [E2]NPY[/E2] gene expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[224, 230]], "entity_1_idx_in_text_with_entity_marker": [228, 234], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[263, 266]], "entity_2_idx_in_text_with_entity_marker": [276, 279], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s431_IEPA.d180.s431.p0", "text": "A loop system exists between hypothalamic neuropeptide Y (NPY) and peripheral adipose tissue leptin to maintain normal body homeostasis", "text_with_entity_marker": "A loop system exists between hypothalamic [E1]neuropeptide Y[/E1] (NPY) and peripheral adipose tissue [E2]leptin[/E2] to maintain normal body homeostasis", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "neuropeptide Y", "entity_1_idx": [[42, 56]], "entity_1_idx_in_text_with_entity_marker": [46, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s442_IEPA.d185.s442.p0", "text": "The ARC NPY neurones are stimulated by starvation, probably mediated by falls in circulating leptin and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit", "text_with_entity_marker": "The ARC [E1]NPY[/E1] neurones are stimulated by starvation, probably mediated by falls in circulating [E2]leptin[/E2] and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[8, 11]], "entity_1_idx_in_text_with_entity_marker": [12, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p0", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC [E1]NPY[/E1] neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which [E2]leptin[/E2] inhibition is lost through mutations affecting leptin or its receptor", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[106, 112]], "entity_2_idx_in_text_with_entity_marker": [119, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d188.s451_IEPA.d188.s451.p0", "text": "We also determined whether well known hypothalamic neuropeptide targets, e.g. neuropeptide Y (NPY), proopiomelanocortin (POMC), agouti-related peptide (AGRP) and cocaine and amphetamine-regulated transcript (CART) were regulated in a pattern consistent with their presumed roles as mediators of leptin action", "text_with_entity_marker": "We also determined whether well known hypothalamic neuropeptide targets, e.g. [E1]neuropeptide Y[/E1] (NPY), proopiomelanocortin (POMC), agouti-related peptide (AGRP) and cocaine and amphetamine-regulated transcript (CART) were regulated in a pattern consistent with their presumed roles as mediators of [E2]leptin[/E2] action", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "neuropeptide Y", "entity_1_idx": [[78, 92]], "entity_1_idx_in_text_with_entity_marker": [82, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[295, 301]], "entity_2_idx_in_text_with_entity_marker": [308, 314], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s475_IEPA.d195.s475.p2", "text": "The current study demonstrates that leptin rapidly influences the secretion of hypothalamic NPY and CRH and that these actions of leptin within the hypothalamus are restrained by the presence of endogenous corticosterone", "text_with_entity_marker": "The current study demonstrates that leptin rapidly influences the secretion of hypothalamic [E1]NPY[/E1] and CRH and that these actions of [E2]leptin[/E2] within the hypothalamus are restrained by the presence of endogenous corticosterone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[92, 95]], "entity_1_idx_in_text_with_entity_marker": [96, 99], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[130, 136]], "entity_2_idx_in_text_with_entity_marker": [143, 149], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
